Search this Site

No Evidence of TRT Link to Prostate Cancer

May 20, 2016
Connect with us

Prostate Cancer Ribbon
Testosterone replacement therapy (TRT) in appropriate patients can lead to a reduced risk of heart attack and stroke, lower blood sugar, reduced belly fat, improved bone density, enhanced sexual function and overall vitality to name a few.

One of the most persistent and damaging medical myths that has lead to the under utilization of TRT is that testosterone causes, or increases the risk of, prostate cancer. Despite the fact that there has never been a single study supporting this myth, and numerous studies over the last several years debunking it, many physicians still have lingering doubts. These doubts have led to the withholding of TRT from countless patients who would benefit from it.

The most recent analysis, No Evidence of TRT Link to Prostate Cancer, not only showed no increased risk of prostate cancer with TRT, but a 50% reduction in the risk of aggressive prostate cancer. And while the researchers emphasize that the results do not prove that TRT has a protective effect on the prostate, the data at least suggests that it does.

For Cenegenics patients, especially those on TRT, the results of this most recent study are not likely to be a surprise, as the evidence continues to confirm the safety and multiple health benefits of TRT in appropriate patients.

If you aren’t a Cenegenics patient and want to learn how our comprehensive wellness programs can work for you, contact me, Dr. Ishman, at Cenegenics Philadelphia.

Connect with us
Posted in Blog, Medical News by admin